Indoco Remedies Ltd

Further to the intimation dated January 23 2023 on the audit conducted by the United States Food and Drug Administration (USFDA) at our Solid Oral Formulation Facility (Plant 1) at Goa from January 16 2023 to January 20 2023 the Company has now received the Establishment Inspection Report (EIR) indicating closure of the inspection.Please find enclosed herewith press release in this regard.Kindly take the above information on record.